Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Carcinoma · PD-1 · Surgery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Ming-Yuan Chen, MD, PhD

    Principal Investigator

    Sun Yat-sen University